Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Nanotechnology ; 34(32)2023 May 24.
Article in English | MEDLINE | ID: mdl-37156235

ABSTRACT

Real-time tracking of dynamic nanoscale processes such as phase transitions by scanning probe microscopy is a challenging task, typically requiring extensive and laborious human supervision. Smart strategies to track specific regions of interest (ROI) in the system during such transformations in a fast and automated manner are necessary to study the evolution of the microscopic changes in such dynamic systems. In this work, we realize automated ROI tracking in piezoresponse force microscopy during a fast (≈0.8°C s-1) thermally stimulated ferroelectric-to-paraelectric phase transition in CuInP2S6. We use a combination of fast (1 frame per second) sparse scanning with compressed sensing image reconstruction and real-time offset correction via phase cross correlation. The applied methodology enablesin situfast and automated functional nanoscale characterization of a certain ROI during external stimulation that generates sample drift and changes local functionality.

2.
Actas urol. esp ; 45(3): 232-238, abril 2021. graf, tab
Article in Spanish | IBECS | ID: ibc-216926

ABSTRACT

Objetivo: Medir la tolerancia del estudio urodinámico (EUD) en el paciente pediátrico, mediante una escala visual analógica. Analizar qué variables clínicas y relacionadas con el EUD influyen en la percepción del dolor.Material y métodosEstudio transversal de 139 pacientes pediátricos tras un EUD (entre diciembre del 2013 a mayo del 2018). Criterio de inclusión: entender y expresar su experiencia tras el EUD (edad preescolar y escolar). No se incluyeron adolescentes.La herramienta de evaluación: escala visual analógica del dolor (EVA 0-10). Se obtuvieron otras variables clínicas y asociadas al EUD. Análisis estadístico: U de Mann-Whitney, Kruskal-Wallis. Análisis de correlación de Spearman (rs). Análisis multivariante mediante regresión logística ordinal. Significación p < 0,05.ResultadosMedia de edad 7,7 años (DE 2,4), mediana puntuación EVA, 2 (2-6). En un 41% (n = 57), la puntuación fue ≥ 4 (dolor moderado). Análisis multivariante. Variables explicativas de obtener una puntuación EVA alta: puntuación APEUD alta (identificar en el paciente nerviosismo previo al EUD), alteración sensitivo-motora de MMII, una dificultad en el sondaje vesical y que aparezca dolor durante el llenado. La edad y el tiempo de duración del EUD no han influido en dicha puntuación EVA.ConclusionesAunque el EUD ha generado que un 40% de los pacientes pediátricos de nuestro estudio expresaran molestias o dolor, es una prueba bien tolerada.Las variables que han influido en la percepción del dolor han sido: el nerviosismo del paciente previo al EUD, una alteración sensitivo-motora localizada en metámeras lumbosacras, una dificultad en el sondaje vesical y que aparezca dolor durante el llenado vesical. (AU)


Objective: To measure the tolerance of urodynamic testing (UDT) in the pediatric patient by means of the Visual Analog Scale (VAS). To analyze which clinical and UDT-related variables influence pain perception. Material and methods. Cross-sectional study of 139 pediatric patients undergoing UDT (December 2013 - May 2018). Inclusion criteria: understanding and expressing their experience after UDT (preschool and school age). No adolescents were included.Measurement instrument Visual Analog Scale (0-10). Other clinical and UDT-associated variables were obtained. Statistical analysis: Mann-Whitney U test, Kruskal Wallis test. Spearman's rank correlation analysis (rs). Multivariate analysis through ordinal logistic regression. Significance p < 0.05.ResultsMean age 7.7 years (SD 2.4), median VAS score, 2 (2-6). In 41% (n = 57), the score was ≥ 4 (moderate pain). Multivariate analysis. Explanatory variables for obtaining a high VAS score: high APUDT score (identifying patient anxiety prior to UDT), sensory-motor alteration in the lower limbs, difficult bladder catheterization and the appearance of pain during the filling phase. Age and duration of the UDT have not influenced the VAS score.ConclusionsAlthough the UDT has resulted in 40% of the pediatric patients in our study expressing discomfort or pain, it is a well-tolerated test.The variables that have influenced on pain perception were patient's anxiety prior to UDT, a sensory-motor alteration located in the lumbosacral metameres, difficult bladder catheterization and the appearance of pain during bladder filling. (AU)


Subject(s)
Humans , Diagnostic Techniques, Urological , Pain Perception , Pain , Urodynamics , Visual Analog Scale , Cross-Sectional Studies
3.
Actas Urol Esp (Engl Ed) ; 45(3): 232-238, 2021 Apr.
Article in English, Spanish | MEDLINE | ID: mdl-33632554

ABSTRACT

OBJECTIVE: To measure the tolerance of urodynamic testing (UDT) in the pediatric patient by means of the Visual Analog Scale (VAS). To analyze which clinical and UDT-related variables influence pain perception. MATERIAL AND METHODS: Cross-sectional study of 139 pediatric patients undergoing UDT (December 2013 - May 2018). INCLUSION CRITERIA: understanding and expressing their experience after UDT (preschool and school age). No adolescents were included. Measurement instrument Visual Analog Scale (0-10). Other clinical and UDT-associated variables were obtained. STATISTICAL ANALYSIS: Mann-Whitney U test, Kruskal Wallis test. Spearman's rank correlation analysis (rs). Multivariate analysis through ordinal logistic regression. Significance p < 0.05. RESULTS: Mean age 7.7 years (SD 2.4), median VAS score, 2 (2-6). In 41% (n = 57), the score was ≥ 4 (moderate pain). Multivariate analysis. Explanatory variables for obtaining a high VAS score: high APUDT score (identifying patient anxiety prior to UDT), sensory-motor alteration in the lower limbs, difficult bladder catheterization and the appearance of pain during the filling phase. Age and duration of the UDT have not influenced the VAS score. CONCLUSIONS: Although the UDT has resulted in 40% of the pediatric patients in our study expressing discomfort or pain, it is a well-tolerated test. The variables that have influenced on pain perception were patient's anxiety prior to UDT, a sensory-motor alteration located in the lumbosacral metameres, difficult bladder catheterization and the appearance of pain during bladder filling.


Subject(s)
Diagnostic Techniques, Urological , Pain Perception , Pain, Procedural , Urodynamics , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Male , Visual Analog Scale
4.
J Assist Reprod Genet ; 37(10): 2443-2451, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32876800

ABSTRACT

RESEARCH QUESTION: Does a freeze-all strategy improve live birth rates in women of different age groups? DESIGN: Retrospective cohort study of 1882 first embryo transfer cycles, performed between January 2013 and December 2015. Reproductive outcomes between fresh (FRESH) or frozen (FROZEN) embryo transfers were compared in patients stratified by age: < 35, between 35 and 38, or > 38 years. Student's t test for independent samples and χ2 analyses were used as needed. A multivariable logistic regression analysis was performed adjusting for age, triggering drug, number of retrieved oocytes, number of transferred embryos, and percentage of top-quality embryos. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth rates (LBR) were significantly higher for FROZEN in the < 35 years group (43.7% vs 24%; p < 0.001). In both the 35-38 and > 38 years groups, LBR for FROZEN vs FRESH were not statistically different (30.9% in the FROZEN group vs 29.3% in the FRESH group, p = 0.70, and 19.8% in the FROZEN group vs 12.7% in the FRESH group, p = 0.07, respectively). The multivariate analysis found a significantly positive effect of performing FROZEN on LBR in the younger group (OR 2.46, 95% CI 1.31-4.62; p = 0.005) but had no impact in women between 35 and 38 years (OR 1.01, 95% CI 0.55-1.83; p = 0.98) or older (OR 0.96, 95% CI 0.43-2.13; p = 0.92). CONCLUSIONS: Performing a freeze-all strategy seems to result in better reproductive outcomes when compared with a fresh ET in women under 35 years, with no significant impact on older women.


Subject(s)
Fertilization in Vitro , Freezing , Live Birth/epidemiology , Pregnancy Rate , Adult , Birth Rate , Cryopreservation , Embryo Transfer/methods , Female , Humans , Middle Aged , Oocyte Retrieval/methods , Pregnancy
5.
J Assist Reprod Genet ; 37(9): 2081-2092, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32578032

ABSTRACT

PURPOSE: Intracytroplasmatic sperm injection (ICSI) is a common procedure used to improve reproductive results, even among couples without male factor infertility. However, the evidence available is still uncertain on the possible advantages and deficiencies that this procedure may have in patients with no formal indication for ICSI. METHODS: A SWOT (strengths, weaknesses, opportunities, threats) analysis examines the possible advantages and deficiencies of performing ICSI in these patients with no formal indication. RESULTS: The evidence suggests that ICSI is not justified for non-male factor infertile couples requiring in vitro conception. One of the major strengths associated to the procedure is the virtual elimination of cases further complicated by total fertilization failure and a combination between IVF and ICSI on sibling oocytes has been advised in the literature. Greater technical difficulties, higher costs and performing an unnecessary invasive technique in some cases represent some of the weaknesses of the procedure, and questions regarding safety issues should not be ruled out. CONCLUSION: Despite the widespread use of ICSI in patients without a formal diagnosis of male factor infertility, evidence demonstrating its effectiveness in this population is still lacking. Additional large and well-designed randomized controlled trials are needed to clarify definitive indications for ICSI in non-male factor infertility.


Subject(s)
Fertilization in Vitro/trends , Infertility, Male/genetics , Sperm Injections, Intracytoplasmic/trends , Spermatozoa/growth & development , Adult , Embryo Transfer , Female , Humans , Infertility, Male/therapy , Male , Oocytes/cytology , Oocytes/growth & development , Pregnancy , Pregnancy Rate , Semen/metabolism
6.
Phys Rev E ; 100(2-1): 022604, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31574759

ABSTRACT

We analyze the frequency dependence of the force between ac-voltage-biased plates in electrolyte solutions. To this end we solve analytically the Poisson-Nernst-Planck transport model in the dilute concentration and low voltage regime for a 1:1 symmetric electrolyte with blocking electrodes under a dc+ac applied voltage. The total force, which is the resultant of the electric and osmotic forces, shows a complex dependence on plate separation, frequency, ion concentration, and compact layer properties, different from that predicted from electrostatic current models or equivalent circuit models, due to the relevance of the osmotic force contribution in almost the whole range of frequencies. For the total dc force, we show that it decays at fixed ion concentration, linearly with plate separation for separations larger than a few times the Debye screening length. This linear dependence is due to the assumption about the conservation of the number of ions in the system. Moreover, the 1ω and 2ω ac harmonics of the total force show a broad peak at intermediate frequencies; it is centered at about the inverse of the charging time of the double layer capacitance, and covers the frequency range between the inverse of the diffusion time and the inverse of the electrolyte dielectric relaxation time. Finally, the 1ω ac harmonic component attains its high frequency asymptotic value at frequencies much higher than the inverse of the electrolyte dielectric relaxation time due to the very slow relaxation of the osmotic 1ω harmonic component at high frequencies. The derived analytical expressions for the total force remain valid up to voltages of the order of the thermal voltage, as has been assessed by means of numerical calculations. The numerical calculations are also used to explore the onset of higher force harmonics for larger applied voltages. Understanding the frequency dependence of the force acting on voltage-biased plates in electrolyte solutions can be of relevance for electrical actuation strategies in microelectromechanical systems and for the interpretation of some emerging electric scanning probe force microscopy techniques operating in electrolyte solutions.

8.
J Hazard Mater ; 369: 70-78, 2019 May 05.
Article in English | MEDLINE | ID: mdl-30772689

ABSTRACT

A graphene oxide-titania (GO/TiO2) composite was synthesized via sol-gel method, and studied in aqueous Primidone mineralization with ozone and LED visible light. The photocatalyst was characterized by different techniques (XRD, TEM, SBET, TGA, UV-vis diffuse reflectance spectroscopy). The band gap value decrease from 3.14 eV for bare TiO2 samples to 2.5 eV in GO/TiO2 composites clearly shows the interaction of GO with TiO2 structure. Approximately 20 mg L-1 of Primidone was removed in less than 20 min if ozone was applied, regardless of the presence or absence of light and catalyst. However, reactivity tests show a synergism effect between photocatalysis and ozonation for mineralization purposes. The combination of ozone and GO improved the activation of TiO2 under visible light. Process optimization led us to select a catalyst dosage of 0.25 g L-1, a light radiance of 359 W m-2 and a GO loading in the catalyst around 0.75%. At these conditions, with photocatalytic ozonation, the presence of GO in the catalyst improved mineralization up to 82% in 2 h compared to 70% reached with bare TiO2. Catalyst reusability shows no decrease of photocatalytic activity. Scavenger tests point to hydroxyl radicals as the main species responsible for Primidone removal.

10.
Reprod Biomed Online ; 37(6): 709-715, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30527061

ABSTRACT

Hysteroscopic septum resection in women with unfavourable reproductive and clinical outcomes has become common practice worldwide to improve reproductive results. No clear evidence on the possible advantages and drawbacks of this procedure has been published. In this opinion paper, based on a SWOT (strengths, weaknesses, opportunities, threats) analysis, the different aspects of this strategy are evaluated. Currently, no level 1 published evidence supports uterine resection in women with septate uterus. Clinical evidence from the studies analysed matches the more recent guidelines and suggests an improvement in reproductive outcomes after hysteroscopic resection of the septum, particularly in infertile women and women who have experienced recurrent miscarriages. In a patient with no history of infertility or prior pregnancy loss, it may be reasonable to consider septum incision after counselling about the potential risks and benefits of the procedure. Published clinical data in favour of the intervention, however, are based on studies with important methodological limitations. In this situation, the clinician and patient should reach an agreement together, based on the pros and cons of this intervention. Well-designed randomized controlled trials are required to confirm the clinical benefits and cost-effectiveness of this procedure.


Subject(s)
Gynecologic Surgical Procedures/statistics & numerical data , Infertility, Female/surgery , Uterus/surgery , Abortion, Habitual , Abortion, Induced , Adult , Female , Gynecologic Surgical Procedures/adverse effects , Humans , Hysteroscopy , Practice Guidelines as Topic , Reproduction , Reproductive Medicine , Treatment Outcome , Uterus/abnormalities
11.
Reprod Biomed Online ; 37(6): 693-702, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30340939

ABSTRACT

RESEARCH QUESTION: To determine whether the transdermal route is equal or superior to the oral route, when preparing the endometrium with oestrogens for embryo transfer. DESIGN: Prospective, randomized controlled trial; 140 patients randomized; the pills group followed a protocol with oestradiol valerate pills and the patches group followed a protocol with oestradiol hemihydrate patches. The primary variable was endometrial thickness on day 10 ± 1 of treatment. Secondary variables were endometrial thickness on day 15 ± 1 of treatment, patient satisfaction, plasma levels of oestradiol, rates of pregnancy, miscarriage and delivery. Endometrial thickness was measured on day 10 ± 1 of the cycle, if the lining was 7 mm or less in thickness, another measurement was made on day 15 ± 1. Blood oestradiol levels were analysed on the day the endometrial lining was greater than 7 mm (day 10 ± 1 or day 15 ± 1). Patients completed a survey to evaluate comfort and side-effects. RESULTS: The patches group achieved significantly thicker endometrium by the first check-up on day 10 ± 1 (7.6 mm versus 7.0 mm; P = 0.026), with lower blood levels of oestradiol (159.2 pg/ml versus 237.1 pg/ml; P < 0.001) when the endometrial thickness was over 7mm. The pills group considered the treatment more comfortable, with less side-effects. No significant differences in the rates of pregnancy, miscarriage or live birth were found. CONCLUSIONS: Transdermal oestrogen treatment allows patients to reach a higher endometrial thickness after 10 days of treatment, with lower plasma levels of oestradiol, although it is not tolerated as well.


Subject(s)
Endometrium/drug effects , Estradiol/administration & dosage , Estrogens/administration & dosage , Ovulation Induction/methods , Administration, Cutaneous , Administration, Oral , Adult , Endometrium/diagnostic imaging , Estradiol/pharmacology , Estrogens/pharmacology , Female , Humans , Pregnancy , Pregnancy Rate , Treatment Outcome
14.
Hum Reprod ; 32(2): 368-374, 2017 02.
Article in English | MEDLINE | ID: mdl-27986819

ABSTRACT

STUDY QUESTION: Does the time from ovum pick-up (OPU) to frozen embryo transfer (FET) affect reproductive outcomes in a freeze-all strategy? SUMMARY ANSWER: Our study did not detect statistically significant differences between first and subsequent cycles, clinically relevant differences are not ruled out and further and larger studies are required. WHAT IS KNOWN ALREADY: Following controlled ovarian hyperstimulation (COH) delaying FET until the endometrium has returned to an optimal pre-stimulation state may have a significant emotional impact on patients, which adds to the stress and anxiety accompanying a standard IVF cycle. Currently there is no agreement on the best time to perform a FET after a freeze-all cycle in order to maximize reproductive outcomes for the patient. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study of 512 freeze-all cycles, performed between January 2012 and December 2014. COH was performed by either a GnRH antagonist (n = 397) or a long GnRH agonist protocol (n = 115). Ovulation was triggered using either a GnRH agonist (n = 258) or hCG (n = 254). Endometrial preparation was performed in an artificial cycle by either oral (n = 238) or transdermal (n = 274) oestrogen. Differences were considered significant if P < 0.05. PARTICIPANTS/MATERIALS, SETTING, METHODS: Reproductive outcomes between FETs which took place either within the first menstrual cycle following OPU (Cycle 1; n = 263) or afterwards (Cycle ≥2; n = 249) were compared. Student's t-test for independent samples, Mann-Whitney U-test and Chi-square analysis were used where appropriate. A multivariable logistic regression analysis was performed adjusting for maternal age, drug used for ovulation trigger, number of retrieved oocytes, number of embryos obtained, day of embryonic development at transfer, number of embryos transferred and type of endometrial preparation. Differences were considered significant if P < 0.05. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth rate (LBR) was significantly higher in FET performed during Cycle 1 vs Cycle ≥2 (37.6% vs 27.3%, respectively; P = 0.01) before adjusting for confounding factors. We found no difference for biochemical pregnancy (49.8% vs 43.8%; P = 0.17), clinical pregnancy (44.1% vs 36.1%; P = 0.07) or pregnancy loss (11.8% vs 16.1%; P = 0.16). A multivariable analysis found no impact of timing of elective FET on LBR (odds ratio, OR 0.73; 95% CI 0.49-1.08). The impact remained not significant after adjusting for number of retrieved oocytes, drug used for ovulation trigger (hCG vs GnRH agonist) and reason for cryopreservation. The factors that significantly affected LBR were: maternal age in both age categories (women between 35 and 40 years vs women below 35 years, OR 0.63, 95% CI 0.4-0.95; and women over 40 years vs women below 35 years, OR 0.34, 95% CI 0.2-0.7), day of embryonic development at transfer (day +4 vs +3; OR 1.7, 95% CI 1.1-2.8) and number of transferred embryos (OR 2.2, 95% CI 1.4-3.3) and oestrogen used for endometrial preparation (transdermal vs oral; OR 0.62, 95% CI 0.4-0.9). LIMITATIONS REASONS FOR CAUTION: The main limitation of our study is its retrospective nature. Although we adjusted our statistical analysis for a number of known and suspected confounders, we cannot exclude the possibility of residual confounding factors. WIDER IMPLICATIONS OF THE FINDINGS: According to our results, clinicians might not need to wait more than one menstrual cycle before performing FET. This allows us to reduce unnecessary delays in FET, without compromising reproductive outcomes. STUDY FUNDING/COMPETING INTERESTS: No funding was sought for this study. Authors declare no competing interests. TRIAL REGISTRATION NUMBER: NA.


Subject(s)
Embryo Transfer/methods , Oocyte Retrieval/methods , Adult , Birth Rate , Cryopreservation , Female , Humans , Live Birth , Ovulation Induction/methods , Pregnancy , Pregnancy Rate , Retrospective Studies , Time Factors
15.
Toxicol Mech Methods ; 26(7): 544-553, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27470987

ABSTRACT

Obesity and emphysema are associated with low-grade systemic inflammation and oxidant stress. Assuming that the oxidant stress induced by emphysema would be decreased by obesity, we analyzed the oxidant/antioxidant state in a rat model combining both diseases simultaneously. Obesity was induced using sucrose, while emphysema by exposure to tobacco smoke. End-points evaluated were: body weight, abdominal fat, plasma dyslipidemia and malondialdehyde (MDA), insulin and glucose AUC, activities of Mn-superoxide dismutase (Mn-SOD), glutathione reductase (GR), glutathione transferase (GST) and glutathione peroxidase (GPx); lung MnSOD and 3-nitrotyrosine (3-NT) immunostaining, and expression of αV and ß6 integrin subunits. In rats with obesity, the body weight, abdominal fat, plasma triglyceride levels, glucose AUC, insulin levels, GST activity, and αV and ß6 integrin expressions were amplified. The rats with emphysema had lower values of body weight, abdominal fat, plasma insulin, triglycerides and glucose AUC but higher values of plasma MDA, GPx activity, and the lung expression of the αV and ß6 integrins. The combination of obesity and emphysema compared to either condition alone led to diminished body weight, abdominal fat, plasma insulin MDA levels, GPx and GST activities, and αV and ß6 integrin expressions; these parameters were all previously increased by obesity. Immunostaining for MnSOD augmented in all experimental groups, but the staining for 3-NT only increased in rats treated with tobacco alone or combined with sucrose. Results showed that obesity reduces oxidant stress and integrin expression, increasing antioxidant enzyme activities; these changes seem to partly contribute to a protective mechanism of obesity against emphysema development.


Subject(s)
Emphysema/metabolism , Lung/drug effects , Nicotiana , Obesity/metabolism , Oxidative Stress/drug effects , Smoke/adverse effects , Animals , Antioxidants/metabolism , Blood Glucose/analysis , Emphysema/chemically induced , Glucose Tolerance Test , Lipid Peroxides/metabolism , Lung/metabolism , Lung/pathology , Male , Obesity/complications , Rats, Wistar , Tobacco Smoke Pollution/adverse effects
17.
Maturitas ; 74(3): 283-90, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23332610

ABSTRACT

Perimenopause is an imprecise period in woman over 40 years of age, which comprises the time between the moment that the first changes in the menstrual cycle appear and the year following the definitive cessation of the menses. Besides irregular bleeding, many women also complain of hot flashes and other characteristic symptoms of postmenopause. Moreover, most of them are concerned about the future impact that these events may have on their health, such as needing health exams or continuing to use contraceptive methods. A panel of experts from the Spanish Menopause Society has met to establish diagnostic and therapeutic guidelines for this period based on the best available evidence.


Subject(s)
Perimenopause/physiology , Adult , Age Factors , Breast Neoplasms/prevention & control , Contraception , Evidence-Based Medicine , Female , Hot Flashes/physiopathology , Humans , Mass Screening , Menopause/physiology , Menstrual Cycle/physiology , Menstruation Disturbances/diagnosis , Menstruation Disturbances/therapy , Middle Aged , Postmenopause/physiology , Spain , Uterine Cervical Neoplasms/prevention & control
18.
Breast ; 22(1): 83-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23141024

ABSTRACT

AIMS OF THE STUDY: The Gail Model (GM) is the most well-known model to assess the individual risk of breast cancer (BC). Although its discriminatory accuracy is low in the clinical context, its usefulness in the screening setting is not well known. The aim of this study is to assess the utility of the GM in a European screening program. METHODS: Retrospective cohort study of 2200 reassessed women with information on the GM available in a BC screening program in Barcelona, Spain. The 5 year-risk of BC applying the GM right after the screening mammogram was compared first with the actual woman's risk of BC in the same screening round and second with the BC risk during the next 5 years. RESULTS: The curves of BC Gail risk overlapped for women with and without BC, both in the same screening episode as well as 5 years afterward. Overall sensitivity and specificity in the same screening episode were 22.3 and 86.5%, respectively, and 46.2 and 72.1% 5 years afterward. ROC curves were barely over the diagonal and the concordance statistics were 0.59 and 0.61, respectively. CONCLUSION: The GM has very low accuracy among women with a positive mammogram result, predicting BC both in the concomitant episode and 5 years later. Our results do not encourage the use of the GM in the screening context to aid the referral decision or the type of procedures after a positive mammogram or to identify women at high risk among those with a false-positive outcome.


Subject(s)
Breast Neoplasms/diagnosis , Decision Support Techniques , Early Detection of Cancer/methods , Mammography , Aged , Algorithms , Breast Neoplasms/diagnostic imaging , Cohort Studies , False Positive Reactions , Female , Follow-Up Studies , Humans , Logistic Models , Middle Aged , Predictive Value of Tests , ROC Curve , Retrospective Studies , Risk Assessment , Sensitivity and Specificity , Spain
19.
Transplant Proc ; 44(9): 2596-8, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146466

ABSTRACT

BACKGROUND: The cytochrome P450 3A5 (CYP3A5) enzyme has been implicated to determine blood pressure (BP) in humans. Different results have been reported concerning CYP3A5 gene polymorphisms and posttransplantation hypertension in kidney recipients. Our objective was to investigate whether CYP3A5 1/3 polymorphism was associated with ambulatory BP among a population of renal transplant recipients receiving the calcineurin inhibitor tacrolimus for immunosuppression. METHODS: Sixty primary kidney transplant recipients undergoing treatment with tacrolimus were genotyped for the CYP3A5 1/3 polymorphism. We analysed the association of the CYP3A5 alleles with ambulatory systolic and diastolic BP measured at 6 and 24 months posttransplantation. RESULTS: We observed that 23.3% of the patients were CYP3A5 1 carriers and 76.7% were homozygous for CYP3A5 3. CYP3A5 1 carriers showed higher adjusted systolic BP and diastolic BP at 6 and 24 months posttransplantation, and they were prescribed more antihypertensive drugs compared with non CYP3A5 1 carrier patients, albeit not significant. No significant differences were found comparing the distribution of the hypertension classes. CONCLUSION: We did not observe a significant association of CYP3A5 1/3 polymorphism with posttransplantation hypertension, although there were some differences in BP associated with the presence of the CYP3A5 1 allele.


Subject(s)
Blood Pressure , Cytochrome P-450 CYP3A/genetics , Hypertension/genetics , Kidney Transplantation/adverse effects , Polymorphism, Genetic , Adult , Antihypertensive Agents/therapeutic use , Blood Pressure/drug effects , Blood Pressure Monitoring, Ambulatory , Calcineurin Inhibitors , Cytochrome P-450 CYP3A/metabolism , Female , Genetic Predisposition to Disease , Heterozygote , Homozygote , Humans , Hypertension/diagnosis , Hypertension/drug therapy , Hypertension/enzymology , Hypertension/physiopathology , Immunosuppressive Agents/metabolism , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Phenotype , Tacrolimus/metabolism , Tacrolimus/therapeutic use , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...